Join Biocom for an exclusive fireside chat with Dr. Peter Schultz, President of The Scripps Research Institute and and Director of the California Institute for Biomedical Research (Calibr). A member of the National Academy of Sciences and the Institute of Medicine, Dr. Schultz is a leader in the field of chemical biology and a serial entrepreneur.  He is a founder of Affymax Research Institute, Symyx Technologies, Syrrx, Kalypsys, Phenomix, Ilypsa, Ambrx, Wildcat Discovery Technologies and Ardelyx, which have pioneered the application of molecular diversity technologies to challenges in energy, materials and human health. He also founded and led the Genomics Institute of the Novartis Research Foundation (GNF) from 1999 to 2010.

Dr. Schultz will speak in an informal setting, sharing his unique insights and “bench-to-bedside” vision for developing long-term strategies and external alliances to facilitate and accelerate the translation of breakthrough scientific discoveries into new medicines.